Abstract Details
|
Ran Liu, MD
(Markham Stouffville Hospital)
PRESENTER |
Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Knight Therapeutics. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Liu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Liu has received research support from Knight Therapeutics. |
| Claire E. Carrazco, DO (Emerson Hospital) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Jason Barton, MD, PhD, FRCPC (Beth Israel Deaconess Medical Center) | The institution of Dr. Barton has received research support from Canada research Chair. Dr. Barton has received publishing royalties from a publication relating to health care. Dr. Barton has received personal compensation in the range of $500-$4,999 for serving as a guideline for vision therapy in MTBI with ICBC. |